Thyroid profile modifications during oral hormone replacement therapy in postmenopausal women

Gynecological Endocrinology

Volumn 12, Issue 3, 1998, Pages 179-184

  Benencia, H ^a,c   Ropelato, M G ^a   Rosales, M ^a   Mesch, V ^a   Siseles, N ^b   Boero, L ^a   Fogel, M ^a   Donato, A M ^a   Petroff, N ^a   Dourisboure, R ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Unidad Asistencial Dr César Milstein   (Argentina)

^c NONE   (Argentina)

Author keywords

Estrogen replacement therapy; Menopause; Thyroid hormones

Indexed keywords

ESTRADIOL VALERATE; ESTROGEN; GESTAGEN; LIOTHYRONINE; NORETHISTERONE ACETATE; PROMEGESTONE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HORMONE SUBSTITUTION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MENOPAUSAL SYNDROME; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 7144227262     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599809015542     Document Type: Article

References (17)

1. Glinoer D, De Nayer P, Bordoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990;71:276-87
2. Emerson CH. Thyroid disease during and after pregnancy. In Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. New York: Raven Publishers, 1995:1263-79
3. Wohllk N, Osorio M, Aguayo J, et al. Thyroid profile in normal pregnancy. Rev Med Chil 1993; 121:652-9
4. Glinoer D. Maternal thyroid function in pregnancy. J Clin Endocrinol Invest 1993;16:374-8
5. O'Leary PC, Boyne P, Atkinson G, et al. Longitudinal study of serum thyroid hormone levels during normal pregnancy. Int J Gynaecol Obstet 1992;38:171-9
6. Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin with increased sialylation a mechanism for estrogen induced elevation of serum TBG concentration. J Clin Endocrinol Metab 1987;65:689-96
7. Sorger D, Schenk S, Schneider G. Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3. Z Gesamte Inn Med 1992;47:58-64
8. Kuhl H, Jung Hoffmann C, Weber J, et al. The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters. Contraception 1993; 47:55-68
9. Kuhl H, Gahn G, Rombert G, et al. A randomized cross over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrine, STH and glucose tolerance. Contraception 1985; 32:97-107
10. Brown JB, Blair HAF. Urinary estrogen metabolites of 19-norethisterone and its esters. Proc Roy Soc Med 1960;53:433
11. Breuer H. Metabolism of progestagens. Lancet 1970;2:615-616
12. Townsley JD, Brodie HJ. Low conversion of 19-norethisterone to urinary estrogens. Lancet 1970;2:1039
13. Rozembaum H. Relationship between clinical, structure and biological properties of progestogens. Am J Obstet Gynecol 1982;142:719-24
14. Reed MJ, Ross MS, Lai LC, et al. In vivo conversion of norethisterone to ethinylestradiol in perimenopausal women. J Steroid Biochem Mol Biol 1990;37:301-3
15. Li QG, Humpel M. Pharmacokinetics, hydrolysis and aromatisation of norethisterone-3-oxima in female cynomolgous monkey. Eur J Drug Metab Pharmacokinet 1992;17:281-91
16. Kleh R, Bathman I, Kuhl H. Formation of ethinyl-estradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate. Maturitas 1995; 21:245-50
17. Abdalla HI, Beastall G, Fletcher D, et al. Sex steroid replacement in post-menopausal women: effects on thyroid hormone status. Maturitas 1987;9:49-54